(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.



Fig. 8. The effects of protein kinase C modulation on Ca2+ transients and STOCs. (A) Following depolarisation from a holding potential of -70 mV to -20 mV (iii), H-7 (10 µM), a protein kinase C inhibitor, had no significant effect on STOC frequency or amplitude (i) or on the ability of carbachol (CCh; iv) to inhibit these responses (i). (B) Following depolarisation from a holding potential of -70 mV to -18 mV, PKC19-36 (3 mM), an impermeant PKC inhibitor added to the patch pipette, failed to affect the ability of either InsP3 ({uparrow}) or CCh (iv) to inhibit STOC frequency or amplitude (i). (C) Following depolarisation from a holding potential of -70 mV to -20 mV (iv) indolactam (10 µM), which activates protein kinase C, slightly decreased [Ca2+]i (ii), did not alter the InsP3-evoked Ca2+ transient ({uparrow}; ii) but significantly reduced STOC frequency (i), see text.